The role of mast cells in common gastrointestinal diseases

Current Allergy and Asthma Reports

Volumn 4, Issue 1, 2004, Pages 47-54

  Siddiqui, Ali A ^a   Miner Jr , Philip B ^a  

^a Oklahoma Foundation for Digestive Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; TRYPTASE;

ALLERGIC REACTION; CELIAC DISEASE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENTERITIS; GASTROENTEROLOGY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SECRETION; HISTAMINE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IRRITABLE COLON; MAST CELL DEGRANULATION; MASTOCYTOSIS; MEDIATOR RELEASE; METABOLISM; PARACRINE SIGNALING; PATHOGENESIS; PERITONEUM MAST CELL; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; CELLULAR IMMUNITY; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; MALE; MAST CELL; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; MALE; MAST CELLS; SENSITIVITY AND SPECIFICITY;

EID: 1542510276     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0043-z     Document Type: Review

References (54)

1. Ehrlich P: Beitrage zur Theorie und Praxis der Histologischen Farbung [doctoral thesis]. University of Leipzig, Germany; 1978.
2. Riley JF, West GB: The presence of histamine in tissue mast cells. J Physiol 1953, 120:528-0.
3. Sanderson IR, Slavin G, Walker-Smith JA: Density of mucosal mast cells in the lamina propria of the colon and terminal ileum of children. J Clin Pathol 1985, 38:771-773.
4. Weidner N, Horan RF, Austen KF: Mast-cell phenotype in indolent forms of mastocytosis: ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase. Am J Pathol 1992, 140:847-857.
5. Pepys J, IgE-mediated hypersensitivity. Clin Sci 1971, 41: 1P-2P.
6. Vaz NM: Behaviour of mouse mast cells during anaphylaxis in vitro. Prog Allergy 1969, 13:111-173.
7. Faquim-Mauro EL, Jacysyn JF, Macedo MS: Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: relevance of proper glycosylation of the molecule. Immunobiology 2003, 207:169-177.
8. Yu LC, Perdue MH: Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001, 179:61-73.
9. MacQueen G, Marshall J, Perdue M, et al.: Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989, 243:83-85.
10. Esposito P, Chandler N, Kandere K, et al.: Corticotrophin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exper Ther 2002, 303:1061-1066.
11. Schwartz LB, Yunginger JW, Miller J, et al.: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Investig 1989, 83:1551-1555.
12. Granerus G, Olafsson JH, Roupe G: Studies on histamine metabolism in mastocytosis. J Investig Dermatol 1983, 80:410-416.
13. Cherner JA, Jensen RT, Dubois A, et al.: Gastrointestinal dysfunction in systemic mastocytosis: a prospective study. Gastroenterology 1988, 95:657-667.
14. Crean GP, Marshall MW, Rumsey RD: Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 1969, 57:147-155.
15. Marks IN: The effect of prolonged histamine stimulation on the parietal cell population and the secretory function of the guinea pig stomach. Q J Exp Physiol A 1957, 42:180-189.
16. Fox LE, Rosenthal RC, Twedt DC, et al.: Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors. J Vet Intern Med 1990, 4:242-246.
17. Castells M, Austen KF: Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol 2002, 127:147-152.
18. Libel R, Biddle WL, Miner PB Jr: Evaluation of anorectal physiology in patients with increased mast cells. Digest Dis Sci 1993, 38:877-881.
19. Crawhall JC, Wilkinson RD: Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition. Clin Invest Med 1987, 10:1-4.
20. Frieri M, Alling DW, Metcalfe D: Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Am J Med 1985, 78:9-14.
21. Friedman B, Santiago M, Berkebile C, et al.: Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis. J Allergy Clin Immunol 1993, 92:520-526.
22. Casassus P, Caillat-Vigneron N, Martin A, et al.: Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol 2002, 119:1090-1097.
23. Kosnai I, Kuitunen P, Savilahti E, Sipponen P: Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood. J Pediatr Gastroenterol Nutr 1984, 3:368-372.
24. Liu S, Hu HZ, Gao N, et al.: Neuroimmune interactions in guinea pig stomach and small intestine. Am J Physiol Gastrointest Liver Physiol 2003, 284:G154-G164.
25. Strobel S, Busuttil A, Ferguson A: Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut 1983, 24:222-227.
26. Lavo B, Knutson L, Loof L, et al.: Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am J Med 1989, 87:655-660.
27. Balazs M, Illyes G, Vadasz G: Mast cells in ulcerative colitis: quantitative and ultrastructural studies. Virchows Arch B Cell Pathol Incl Mol Pathol 1989, 57:353-360.
28. Bischoff SC, Wedemeyer J, Herrmann A, et al.: Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996, 28:1-13.
29. Lloyd G, Green FH, Fox H, et al.: Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 1975, 16:861-866.
30. Sarin SK, Malhotra V, Sen Gupta S, et al.: Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis: a prospective controlled study. Digest Dis Sci 1987, 32:363-367.
31. Kosnai I, Kuitunen P, Savilahti E, Sipponen P: Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood. J Pediatr Gastroenterol Nutr 1984, 3:368-372.
32. Pearce FL, Frenz AM, Shah PM: Changes in mast cell reactivity in the course of allergic inflammation. Inflamm Res 1996, 45(Suppl 1):S31-S32.
33. Stoyanova II, Gulubova MV: Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 2002, 104:185-192.
34. Bischoff SC, Schwengberg S, Wordelmann K, et al.: Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996, 38:104-114.
35. Wedemeyer J, Galli SJ: Mast cells and basophils in acquired immunity. Br Med Bull 2000, 56:936-955.
36. Bischoff SC, Lorentz A, Schwengberg S, et al.: Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999, 44:643-652.
37. Xia Y, Hu HZ, Liu S, et al.: Clostridium difficile toxin A excites enteric neurones and suppresses sympathetic neurotransmission in the guinea pig. Gut 2000, 46:481-486.
38. Kurose I, Pothoulakis C, LaMont JT, et al.: Clostridium difficile toxin A-induced microvascular dysfunction: role of histamine. J Clin Investig 1994, 94:1919-1926.
39. Santos J, Saunders PR, Hanssen NP, et al.: Corticotrophin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999, 277(2 Pt 1):G391-G399.
40. King T, Biddle W, Bhatia P, et al.: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Digest Dis Sci 1992, 37:490-495.
41. Stead RH, Dixon MF, Bramwell NH, et al.: Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989, 97:575-585.
42. Wood JD: Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 2002, 35(Suppl 1):S11-S22.
43. Chaudhary NA, Truelove SC: The irritable colon syndrome: a study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962, 31:307-322.
44. Zwetchkenbaum JF, Burakoff R: Food allergy and the irritable bowel syndrome. Am J Gastroenterol 1988, 83:901-904.
45. Mullin GE: Food allergy and irritable bowel syndrome. JAMA 1991, 265:1736.
46. Gue M, Del Rio-Lacheze C, Bueno L: Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997, 9:271-279.
47. Bueno L, Fioramonti J: Effects of inflammatory mediators on gut sensitivity. Can J Gastroenterol 1999, 13(Suppl A):42A-46A.
48. Libel R, Biddle WL, Miner PB Jr: Evaluation of anorectal physiology in patients with increased mast cells. Digest Dis Sci 1993, 38:877-881.
49. Whitehead WE, Palsson OS: Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998, 115:1263-1271.
50. Whitehead WE, Crowell MD, Davidoff AL, et al.: Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Digest Dis Sci 1997, 42:796-804.
51. Su X, Gebhart GF: Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain 1998, 76:105-114.
52. Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 1994, 8:409-416.
53. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr: Terminal ileal mucosal mast cells in irritable bowel syndrome. Digest Dis Sci 1993, 38:1590-1595.
54. Matter SE, Bhatia PS, Miner PB Jr: Evaluation of antral mast cells in nonulcer dyspepsia. Digest Dis Sci 1990, 35:1358-1363.